Published in Bone on June 06, 2008
Iroquois Proteins Promote Skeletal Joint Formation by Maintaining Chondrocytes in an Immature State. Dev Cell (2015) 1.50
Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses. Dev Dyn (2013) 1.08
Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry (2010) 1.04
Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol (2013) 0.99
Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res (2011) 0.98
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol (2014) 0.94
Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin. J Biol Chem (2010) 0.93
Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostoses. Am J Pathol (2015) 0.90
Heparanase isoform expression and extracellular matrix remodeling in intervertebral disc degenerative disease. Clinics (Sao Paulo) (2011) 0.85
Extracellular matrix remodeling in experimental intervertebral disc degeneration. Acta Ortop Bras (2013) 0.84
Systems genetics analysis of mouse chondrocyte differentiation. J Bone Miner Res (2011) 0.84
Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment. J Cell Biochem (2014) 0.80
Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix. Matrix Biol (2015) 0.79
Deficiency in perlecan/HSPG2 during bone development enhances osteogenesis and decreases quality of adult bone in mice. Calcif Tissue Int (2014) 0.79
Increased expression of heparanase in osteogenic differentiation of rat marrow stromal cells. Exp Ther Med (2013) 0.75
Identification of novel genetic variations affecting osteoarthritis patients. BMC Med Genet (2016) 0.75
The Schwartz-Jampel syndrome: Case report and review of literature. Adv Biomed Res (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Hedgehog signaling in animal development: paradigms and principles. Genes Dev (2001) 14.75
Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science (1996) 8.14
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Bone development. Annu Rev Cell Dev Biol (2000) 4.24
Heparin structure and interactions with basic fibroblast growth factor. Science (1996) 3.00
Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol (1999) 2.94
Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage (2000) 2.77
Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta (2001) 2.74
Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim Biophys Acta (1977) 2.43
Perlecan is essential for cartilage and cephalic development. Nat Genet (1999) 2.21
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des (2007) 2.14
Heparanase as mediator of angiogenesis: mode of action. FASEB J (2001) 2.04
Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem (2007) 2.03
The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of hedgehog signaling peptides. Dev Biol (2001) 1.98
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol (1999) 1.93
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol (2004) 1.88
Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology (1996) 1.86
Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A (2000) 1.82
Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J (2004) 1.64
Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol (2004) 1.64
BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol (2000) 1.61
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem (1984) 1.56
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem (2003) 1.53
Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation (1999) 1.52
How proteases regulate bone morphogenesis. Ann N Y Acad Sci (2003) 1.47
Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res (1997) 1.46
Development of heparanase inhibitors for anti-cancer therapy. Curr Med Chem (2006) 1.41
Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development (2007) 1.40
Expression of angiogenic factors during distraction osteogenesis. Bone (2003) 1.39
FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev Biol (2006) 1.36
Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development (2005) 1.34
The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun (2005) 1.33
Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol (1999) 1.33
Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J (2005) 1.32
Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest (1985) 1.27
Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling. Dev Biol (2002) 1.24
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem (2003) 1.23
Calcium-and integrin-binding protein regulates focal adhesion kinase activity during platelet spreading on immobilized fibrinogen. Blood (2003) 1.20
Heterodimer formation is essential for heparanase enzymatic activity. Biochem Biophys Res Commun (2003) 1.17
Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology (2001) 1.16
The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J Endocrinol (2006) 1.14
Chondrocyte moves: clever strategies? Osteoarthritis Cartilage (2007) 1.13
Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J (1997) 1.13
Fibroblast growth factor expression in the postnatal growth plate. Bone (2006) 1.13
Sequence variation in heparin octasaccharides with high affinity for antithrombin III. Biochemistry (1984) 1.12
Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol (2006) 1.11
Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J Biol Chem (1996) 1.10
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res (2002) 1.09
Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway. Mol Cancer (2006) 1.08
Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng (2006) 1.06
Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem (1993) 1.01
Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures. Mech Dev (2004) 0.98
Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie (2001) 0.98
Combination of osteoinductive bone proteins differentiates mesenchymal C3H/10T1/2 cells specifically to the cartilage lineage. J Cell Biochem (1997) 0.98
Heparan sulfate proteoglycans: key players in cartilage biology. Crit Rev Eukaryot Gene Expr (2005) 0.98
Syndecan-3, tenascin-C, and the development of cartilaginous skeletal elements and joints in chick limbs. Dev Dyn (1995) 0.97
Indian hedgehog in the late-phase differentiation in mouse chondrogenic EC cells, ATDC5: upregulation of type X collagen and osteoprotegerin ligand mRNAs. Biochem Biophys Res Commun (1999) 0.94
Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J Biol Chem (1995) 0.93
A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. J Am Soc Nephrol (2004) 0.93
Cloning, expression, and purification of mouse heparanase. Protein Expr Purif (2002) 0.92
Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today (2004) 0.92
Midkine is expressed during repair of bone fracture and promotes chondrogenesis. J Bone Miner Res (1999) 0.92
Aggregation of hydroxyapatite crystals. Biochim Biophys Acta (1976) 0.92
Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton. Cells Tissues Organs (2005) 0.90
HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation (2003) 0.89
Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J Endocrinol (2002) 0.89
Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthritis Cartilage (2001) 0.88
A novel in vitro culture system for analysis of functional role of phosphate transport in endochondral ossification. Bone (2000) 0.87
Evidence that platelet and tumour heparanases are similar enzymes. Biochem J (1999) 0.86
Gene expression profiling following BMP-2 induction of mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage (2002) 0.86
Production of heparanase by normal and neoplastic murine B-lymphocytes. Int J Cancer (1991) 0.86
Cell density dependent regulation of AP-1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells. J Cell Biochem (2002) 0.86
PTH has the potential to rescue disturbed bone growth in achondroplasia. Bone (2007) 0.85
Characterization of heparanase from a rat parathyroid cell line. J Biol Chem (2002) 0.84
Heparanase expression and function during early pregnancy in mice. Biol Reprod (2007) 0.84
Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate. Biochem J (1989) 0.83
Mechanisms of morphogen movement. J Neurobiol (2005) 0.83
Pleiotrophin inhibits chondrocyte proliferation and stimulates proteoglycan synthesis in mature bovine cartilage. Matrix Biol (1999) 0.82
Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Dev Dyn (1996) 0.81
Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro. Connect Tissue Res (2003) 0.81
Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts. Differentiation (2006) 0.80
Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development. Histochem Cell Biol (2006) 0.78
Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem (1993) 2.27
Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and alpha 2HS-glycoprotein) proteins in rat bone. J Bone Miner Res (1993) 1.58
Expression and steroid hormonal control of Muc-1 in the mouse uterus. Endocrinology (1995) 1.45
The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopment. J Gen Virol (2000) 1.45
The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection. J Gen Virol (2000) 1.42
Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit in vitro. J Virol (1993) 1.35
Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol (1999) 1.33
Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo. Virology (1992) 1.33
The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neurovirulence and latency in mice. Virology (1993) 1.32
Isolation, characterization and immunolocalization of a 53-kDal dentin sialoprotein (DSP). Matrix (1992) 1.27
Mammalian reproductive tract mucins. Hum Reprod Update (1999) 1.25
Mitochondrial distribution and function in herpes simplex virus-infected cells. J Gen Virol (2000) 1.24
MUC1/episialin: a critical barrier in the female reproductive tract. J Reprod Immunol (1999) 1.22
Synthesis, subcellular localization and VP16 interaction of the herpes simplex virus type 2 UL46 gene product. Arch Virol (2000) 1.21
Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc Natl Acad Sci U S A (2004) 1.20
The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J Infect Dis (1991) 1.16
Characterization of the UL16 gene product of herpes simplex virus type 2. Arch Virol (1998) 1.15
A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities. Proc Natl Acad Sci U S A (1997) 1.12
Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit. J Virol (1993) 1.11
Bacterial conjunctivitis in Muc1 null mice. Invest Ophthalmol Vis Sci (1999) 1.11
Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clin Genet (2011) 1.10
Effects of fatty acids on lysis of Streptococcus faecalis. J Bacteriol (1980) 1.09
Herpes simplex virus encodes a virion-associated protein which promotes long cellular processes in over-expressing cells. Genes Cells (2001) 1.09
Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells (2000) 1.08
Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity. J Oral Pathol Med (1999) 1.06
Memory-type CD8+ T cells protect IL-2 receptor alpha-deficient mice from systemic infection with herpes simplex virus type 2. J Immunol (2000) 1.05
Enhancement of protein glycosylation in tissue slices by dolichylphosphate. J Biol Chem (1981) 1.04
Inhibition of polyisoprenoid and glycoprotein biosynthesis causes abnormal embryonic development. Proc Natl Acad Sci U S A (1979) 1.04
Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol (1987) 1.02
Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J Biol Chem (1989) 1.02
Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res (1994) 1.02
Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res (1994) 1.01
Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng (2005) 1.00
A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology (2000) 1.00
Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95). J Biol Chem (1992) 0.99
The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice. Arch Virol (1993) 0.99
Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2. J Virol (1991) 0.99
Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ (2001) 0.98
Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. J Bone Miner Res (2000) 0.98
Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation. Dev Biol (1997) 0.97
Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: implications for enhanced growth in the bone microenvironment. Matrix Biol (2001) 0.97
Secretion and hormonal regulation of interleukin-6 production by mouse uterine stromal and polarized epithelial cells cultured in vitro. Endocrinology (1992) 0.97
Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus. J Virol (1996) 0.97
Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone (2009) 0.97
Molecular complexity in establishing uterine receptivity and implantation. Cell Mol Life Sci (2005) 0.97
Polyadenylation at a cryptic site in the pBR322 portion of pSV2-neo: prevention of its utilization by the SV40 late poly(A) signal. Nucleic Acids Res (1987) 0.96
MUC1 expression in human prostate cancer cell lines and primary tumors. Prostate Cancer Prostatic Dis (2005) 0.96
A monoclonal antibody inhibits calcium accumulation and skeleton formation in cultured embryonic cells of the sea urchin. Cell (1985) 0.95
Calcium signals and calcium channels in osteoblastic cells. Semin Nephrol (1998) 0.95
Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase. Virology (1996) 0.95
Progesterone and implanting blastocysts regulate Muc1 expression in rabbit uterine epithelium. Endocrinology (1998) 0.95
Bone matrix proteins in osteogenesis and remodelling in the neonatal rat mandible as studied by immunolocalization of osteopontin, bone sialoprotein, alpha 2HS-glycoprotein and alkaline phosphatase. Arch Oral Biol (1995) 0.94
Relationship of dolichol synthesis to glycoprotein synthesis during embryonic development. J Biol Chem (1981) 0.94
The UL14 protein of herpes simplex virus type 2 translocates the minor capsid protein VP26 and the DNA cleavage and packaging UL33 protein into the nucleus of coexpressing cells. J Gen Virol (2001) 0.94
Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J Bone Miner Res (1993) 0.94
1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol (1992) 0.94
A single mutation responsible for temperature-sensitive entry and assembly defects in the VP1-2 protein of herpes simplex virus. J Virol (2010) 0.93
Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells. Arch Virol (2000) 0.93
cDNA cloning and expression of HIP, a novel cell surface heparan sulfate/heparin-binding protein of human uterine epithelial cells and cell lines. J Biol Chem (1996) 0.93
The product of the US10 gene of herpes simplex virus type 1 is a capsid/tegument-associated phosphoprotein which copurifies with the nuclear matrix. J Gen Virol (1997) 0.92
Synthesis and intracellular trafficking of Muc-1 and mucins by polarized mouse uterine epithelial cells. J Biol Chem (1996) 0.92
Mucin (Muc-1) expression is differentially regulated in uterine luminal and glandular epithelia of the baboon (Papio anubis). Biol Reprod (1996) 0.92
Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell (1993) 0.92
Characterization of the herpes simplex virus (HSV)-1 tegument protein VP1-2 during infection with the HSV temperature-sensitive mutant tsB7. J Gen Virol (2009) 0.91
Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells. Clin Exp Metastasis (1999) 0.91
Extraction and isolation of glycoproteins and proteoglycans. Biotechniques (1989) 0.91
Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat. J Bone Miner Res (1994) 0.91
Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J Biol Chem (1993) 0.90
Effect of cerulenin on cellular autolytic activity and lipid metabolism during inhibition of protein synthesis in Streptococcus faecalis. J Bacteriol (1981) 0.90
Comparison of capillary blood versus venous blood samples in the assessment of immunity to measles. J Virol Methods (1996) 0.90
Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion. Development (1994) 0.90
Developmental expression of a 53 KD dentin sialoprotein in rat tooth organs. J Histochem Cytochem (1992) 0.89
Modulation of osteopontin post-translational state by 1, 25-(OH)2-vitamin D3. Dependence on Ca2+ influx. J Biol Chem (1998) 0.89
Ribozyme ablation demonstrates that the cardiac subtype of the voltage-sensitive calcium channel is the molecular transducer of 1, 25-dihydroxyvitamin D(3)-stimulated calcium influx in osteoblastic cells. J Biol Chem (2000) 0.89
Subcellular localization of the US3 protein kinase of herpes simplex virus type 2. Arch Virol (1998) 0.89
Heparin/heparan sulfate (HP/HS) interacting protein (HIP) supports cell attachment and selective, high affinity binding of HP/HS. J Biol Chem (1997) 0.89
Development of morphological and functional polarity in primary cultures of immature rat uterine epithelial cells. J Cell Biol (1988) 0.89
Reduction of mucin-1 expression during the receptive phase in the rat uterus. Biol Reprod (1998) 0.89
Evidence for the formation of a complex between osteopontin and osteocalcin. J Bone Miner Res (1992) 0.88
Differential temporal and spatial expression of mRNA encoding extracellular matrix components in decidua during the peri-implantation period. Biol Reprod (1992) 0.88
Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem Biophys Res Commun (1998) 0.88
Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins. Cell Calcium (2000) 0.88
Overexpression, purification and helix-destabilizing properties of Epstein-Barr virus ssDNA-binding protein. J Gen Virol (1998) 0.88
A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment. J Biol Chem (1998) 0.88
Rescue of motoneurons from cell death by a purified skeletal muscle polypeptide: effects of the ChAT development factor, CDF. Neuron (1990) 0.87
Characterization of yolk platelets isolated from developing embryos of Arbacia punctulata. Dev Biol (1986) 0.87
A single enzyme catalyzes the synthesis of the mannosylphosphoryl derivative of dolichol and retinol in rat liver and Chinese hamster ovary cells. J Biol Chem (1985) 0.87
Cell surface expression of HIP, a novel heparin/heparan sulfate binding protein, of human uterine epithelial cells and cell lines. J Biol Chem (1996) 0.87
Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: possible involvement of superoxide radicals. Arch Virol (1992) 0.87
Regional specialization of the cell membrane-associated, polymorphic mucin (MUC1) in human uterine epithelia. Hum Reprod (1998) 0.87
Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neurooncol (1994) 0.87
Uterine epithelial cell secretion of interleukin-1 alpha induces prostaglandin E2 (PGE2) and PGF2 alpha secretion by uterine stromal cells in vitro. Endocrinology (1993) 0.87
Identification and characterization of the UL14 gene product of herpes simplex virus type 2. J Gen Virol (1999) 0.86
Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro. J Antibiot (Tokyo) (1989) 0.86
Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate. J Biol Chem (1997) 0.86